PolyPeptide Group AG (PPGN) CHF0.01

Sell:23.40 CHFBuy:23.55 CHF0.10 CHF (0.43%)

Prices delayed by at least 15 minutes
Sell:23.40 CHF
Buy:23.55 CHF
Change:0.10 CHF (0.43%)
Deal now
Prices delayed by at least 15 minutes
Sell:23.40 CHF
Buy:23.55 CHF
Change:0.10 CHF (0.43%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.

Key people

Juan-Jose Gonzalez
Chief Executive Officer
Marc Augustin
Chief Financial Officer
Christina Del Vecchio
General Counsel, Corporate Secretary
Raoul Bernhardt
Chief Manufacturing and Supply Chain Officer
Peter Wilden
Non-Executive Chairman of the Board
Patrick Aebischer
Non-Executive Vice Chairman of the Board, Lead Independent Director
Jane Salik
Non-Executive Director
Erik Schropp
Non-Executive Director
Joanna Lecouilliard
Non-Executive Independent Director
Click to see more

Key facts

  • Shares in issue
    33.13m
  • EPIC
    PPGN
  • ISIN
    CH1110760852
  • Location
    Switzerland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    CHF 775.15m
  • Employees
    1,366
  • Exchange
    SIX Swiss Exchange
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.